About Icons

Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

Oxybutynin, tolterodine, solifenacin
(D01269)

[3] Oxybutynin,
Solifenacin,
Tolterodine

[6] Oxybutynin ,
Tolterodine ,
Oxybutynin chloride ,
Tolterodine tartrate ,
Solifenacin succinate (D01269),
Solifenacin 💬

Name	Other Names
Oxybutynin	Anturol Oxytrol
Tolterodine	Tolterodine
Oxybutynin chloride	Oxybutynin hydrochloride Ditropan Gelnique
Tolterodine tartrate	Detrol Detrusitol
Solifenacin succinate	Vesicare
Solifenacin	Solifenacin

[5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬

Name	Full Name
CHRM1	muscarinic acetylcholine receptor M1
CHRM2	muscarinic acetylcholine receptor M2
CHRM3	muscarinic acetylcholine receptor M3
CHRM4	muscarinic acetylcholine receptor M4
CHRM5	muscarinic acetylcholine receptor M5

[14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬

[1] 53 💬

2

Solifenacin
(D01269)

[1] Solifenacin

[2] Solifenacin succinate (D01269),
Solifenacin 💬

[1] CHRM3 💬

[12] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬

[3] 6, 13, 53 💬

3

Solifenacin Succinate
(D01269)

[1] Solifenacin

[2] Solifenacin succinate (D01269),
Solifenacin 💬

[1] CHRM3 💬

[12] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬

[1] 13 💬

4

Solifenacin Succinate (VESIcare)
(D01269)

[1] Solifenacin

[2] Solifenacin succinate (D01269),
Solifenacin 💬

[1] CHRM3 💬

[12] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬

[1] 6 💬